The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $356.25 million. The enterprise value is $429.51 million.
Important Dates
The next confirmed earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 93.50 million shares outstanding. The number of shares has increased by 8.50% in one year.
| Current Share Class | 93.50M |
| Shares Outstanding | 93.50M |
| Shares Change (YoY) | +8.50% |
| Shares Change (QoQ) | +20.89% |
| Owned by Insiders (%) | 7.93% |
| Owned by Institutions (%) | 35.42% |
| Float | 77.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| Forward PS | 0.68 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62
| Current Ratio | 1.62 |
| Quick Ratio | 1.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.33 |
Financial Efficiency
Return on equity (ROE) is -651.69% and return on invested capital (ROIC) is -23.94%.
| Return on Equity (ROE) | -651.69% |
| Return on Assets (ROA) | -17.27% |
| Return on Invested Capital (ROIC) | -23.94% |
| Return on Capital Employed (ROCE) | -49.36% |
| Revenue Per Employee | $514,395 |
| Profits Per Employee | -$65,605 |
| Employee Count | 825 |
| Asset Turnover | 2.50 |
| Inventory Turnover | 26.61 |
Taxes
| Income Tax | -131,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,260.71% in the last 52 weeks. The beta is 0.16, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +1,260.71% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 2.63 |
| Relative Strength Index (RSI) | 40.65 |
| Average Volume (20 Days) | 2,146,089 |
Short Selling Information
The latest short interest is 5.83 million, so 6.24% of the outstanding shares have been sold short.
| Short Interest | 5.83M |
| Short Previous Month | 5.10M |
| Short % of Shares Out | 6.24% |
| Short % of Float | 7.52% |
| Short Ratio (days to cover) | 3.40 |
Income Statement
In the last 12 months, TOI had revenue of $424.38 million and -$54.12 million in losses. Loss per share was -$0.67.
| Revenue | 424.38M |
| Gross Profit | 63.75M |
| Operating Income | -46.90M |
| Pretax Income | -66.02M |
| Net Income | -54.12M |
| EBITDA | -40.04M |
| EBIT | -46.90M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $30.29 million in cash and $103.55 million in debt, giving a net cash position of -$73.26 million or -$0.78 per share.
| Cash & Cash Equivalents | 30.29M |
| Total Debt | 103.55M |
| Net Cash | -73.26M |
| Net Cash Per Share | -$0.78 |
| Equity (Book Value) | -8.99M |
| Book Value Per Share | -0.10 |
| Working Capital | 40.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.19 million and capital expenditures -$2.89 million, giving a free cash flow of -$13.07 million.
| Operating Cash Flow | -10.19M |
| Capital Expenditures | -2.89M |
| Free Cash Flow | -13.07M |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
Gross margin is 15.02%, with operating and profit margins of -11.05% and -15.53%.
| Gross Margin | 15.02% |
| Operating Margin | -11.05% |
| Pretax Margin | -15.56% |
| Profit Margin | -15.53% |
| EBITDA Margin | -9.43% |
| EBIT Margin | -11.05% |
| FCF Margin | n/a |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.50% |
| Shareholder Yield | -8.50% |
| Earnings Yield | -15.19% |
| FCF Yield | -3.67% |
Analyst Forecast
The average price target for TOI is $6.50, which is 70.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 70.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TOI has an Altman Z-Score of 0.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.11 |
| Piotroski F-Score | 3 |
